Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (19015)
All Articles published online
|
Publishing Process of This Article
|
Aug 14, 2016 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hu T, Li Z, Gao CY, Cho CH. Mechanisms of drug resistance in colon cancer and its therapeutic strategies. World J Gastroenterol 2016; 22(30): 6876-6889 [PMID: 27570424 DOI: 10.3748/wjg.v22.i30.6876] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i30/6876.htm |
| Number | Citing Articles |
| 1 |
Jing Liang, Xiao-Feng Tian, Wei Yang. Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137. World Journal of Gastroenterology 2020; 26(13): 1474-1489 doi: 10.3748/wjg.v26.i13.1474
|
| 2 |
Aditya Kumar, Yashika Uniyal, Roshan Kumar. Recent Advancement of Colorectal Cancer and Their Herbal Essential Oil Treatment. Journal for Research in Applied Sciences and Biotechnology 2022; 1(5): 133 doi: 10.55544/jrasb.1.5.15
|
| 3 |
Morvarid Siri, Hamid Behrouj, Sanaz Dastghaib, Mozhdeh Zamani, Wirginia Likus, Sedigheh Rezaie, Jacek Hudecki, Saeed Khazayel, Marek J. Łos, Pooneh Mokarram, Saeid Ghavami. Casein Kinase-1-Alpha Inhibitor (D4476) Sensitizes Microsatellite Instable Colorectal Cancer Cells to 5-Fluorouracil via Authophagy Flux Inhibition. Archivum Immunologiae et Therapiae Experimentalis 2021; 69(1) doi: 10.1007/s00005-021-00629-2
|
| 4 |
Simona-Ruxandra Volovat, Iolanda Augustin, Daniela Zob, Diana Boboc, Florin Amurariti, Constantin Volovat, Cipriana Stefanescu, Cati Raluca Stolniceanu, Manuela Ciocoiu, Eduard Alexandru Dumitras, Mihai Danciu, Delia Gabriela Ciobanu Apostol, Vasile Drug, Sinziana Al Shurbaji, Lucia-Georgiana Coca, Florin Leon, Adrian Iftene, Paul-Corneliu Herghelegiu. Use of Personalized Biomarkers in Metastatic Colorectal Cancer and the Impact of AI. Cancers 2022; 14(19): 4834 doi: 10.3390/cancers14194834
|
| 5 |
Like Zhong, Junfeng Zhu, Qi Shu, Gaoqi Xu, Chaoneng He, Luo Fang, Yanqing Liu. A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma. Journal of Oncology 2023; 2023: 1 doi: 10.1155/2023/5925935
|
| 6 |
Fei Wang, Dinglan Wu, Jianxiang Chen, Shiliang Chen, Fengrong He, Housheng Fu, Qinghui Wu, Shuan Liu, Xionggen Li, Weifu Wang. Long non-coding RNA HOXA-AS2 promotes the migration, invasion and stemness of bladder cancer via regulating miR-125b/Smad2 axis. Experimental Cell Research 2019; 375(1): 1 doi: 10.1016/j.yexcr.2018.11.005
|
| 7 |
Li‐guang Yang, Ming‐zheng Cao, Jie Zhang, Xiao‐yan Li, Qin‐li Sun. LncRNA XIST modulates HIF‐1A/AXL signaling pathway by inhibiting miR‐93‐5p in colorectal cancer. Molecular Genetics & Genomic Medicine 2020; 8(4) doi: 10.1002/mgg3.1112
|
| 8 |
Sheng Zhang, Treena Chatterjee, Carla Godoy, Ling Wu, Qingyun J. Liu, Kendra S. Carmon. GPR56 Drives Colorectal Tumor Growth and Promotes Drug Resistance through Upregulation of MDR1 Expression via a RhoA-Mediated Mechanism. Molecular Cancer Research 2019; 17(11): 2196 doi: 10.1158/1541-7786.MCR-19-0436
|
| 9 |
Ashraf N. Abdalla, Waleed H. Malki, Amal Qattan, Imran Shahid, Mohammad Akbar Hossain, Muhammad Ahmed. Chemosensitization of HT29 and HT29-5FU Cell Lines by a Combination of a Multi-Tyrosine Kinase Inhibitor and 5FU Downregulates ABCC1 and Inhibits PIK3CA in Light of Their Importance in Saudi Colorectal Cancer. Molecules 2021; 26(2): 334 doi: 10.3390/molecules26020334
|
| 10 |
Lyudmila Ounpuu, Laura Truu, Igor Shevchuk, Vladimir Chekulayev, Aleksandr Klepinin, Andre Koit, Kersti Tepp, Marju Puurand, Egle Rebane-Klemm, Tuuli Käämbre. Comparative analysis of the bioenergetics of human adenocarcinoma Caco-2 cell line and postoperative tissue samples from colorectal cancer patients. Biochemistry and Cell Biology 2018; 96(6): 808 doi: 10.1139/bcb-2018-0076
|
| 11 |
Sara Shamekhi, Jalal Abdolalizadeh, Alireza Ostadrahimi, Seyyed Abolghasem Mohammadi, Abolfazl Barzegari, Hajie Lotfi, Esat Bonabi, Nosratollah Zarghami. Apoptotic Effect of Saccharomyces cerevisiae on Human Colon Cancer SW480 Cells by Regulation of Akt/NF-ĸB Signaling Pathway. Probiotics and Antimicrobial Proteins 2020; 12(1): 311 doi: 10.1007/s12602-019-09528-7
|
| 12 |
Giulia Lori, Paolo Paoli, Angelo Pietro Femia, Erica Pranzini, Anna Caselli, Katia Tortora, Andrea Romagnoli, Giovanni Raugei, Giovanna Caderni. Morin‐dependent inhibition of low molecular weight protein tyrosine phosphatase (LMW‐PTP) restores sensitivity to apoptosis during colon carcinogenesis: Studies in vitro and in vivo, in an Apc‐driven model of colon cancer. Molecular Carcinogenesis 2019; 58(5): 686 doi: 10.1002/mc.22962
|
| 13 |
Winnie Fong, Kenneth K. W. To. Drug repurposing to overcome resistance to various therapies for colorectal cancer. Cellular and Molecular Life Sciences 2019; 76(17): 3383 doi: 10.1007/s00018-019-03134-0
|
| 14 |
Zhuo Wu, Su Zhou, Dan Liang, Lan Mu. GPX2 acts as an oncogene and cudraflavone C has an anti-tumor effect by suppressing GPX2-dependent Wnt/β-catenin pathway in colorectal cancer cells. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(2): 1115 doi: 10.1007/s00210-023-02668-2
|
| 15 |
Lijun Ma, Fangfang Ai, Hongyan Xiao, Fang Wang, Lei Shi, Xuehong Bai, Yongzhao Zhu, Wenping Ma. Lycium barbarum polysaccharide reverses drug resistance in oxaliplatin-resistant colon cancer cells by inhibiting PI3K/AKT-dependent phosphomannose isomerase. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1367747
|
| 16 |
Raghvendra Pandey, Prashant Kumar Singh, Alok Kumar Shrivastava. Colon Cancer Diagnosis and Therapy. 2021; : 269 doi: 10.1007/978-3-030-64668-4_13
|
| 17 |
Jianing Gong, Taoran Shi, Jinfeng Liu, Zerong Pei, Jingbo Liu, Xiaoliang Ren, Fengyun Li, Feng Qiu. Dual-drug codelivery nanosystems: An emerging approach for overcoming cancer multidrug resistance. Biomedicine & Pharmacotherapy 2023; 161: 114505 doi: 10.1016/j.biopha.2023.114505
|
| 18 |
Reza Seyyedi, Fereshteh Talebpour Amiri, Soghra Farzipour, Ehsan Mihandoust, Seyed Jalal Hosseinimehr. Mefenamic acid as a promising therapeutic medicine against colon cancer in tumor-bearing mice. Medical Oncology 2022; 39(2) doi: 10.1007/s12032-021-01618-3
|
| 19 |
Ankur Sood, Atul Dev, Soni Jignesh Mohanbhai, Nishith Shrimali, Meena Kapasiya, Avinash Chandra Kushwaha, Subhasree Roy Choudhury, Prasenjit Guchhait, Surajit Karmakar. Disulfide-Bridged Chitosan-Eudragit S-100 Nanoparticles for Colorectal Cancer. ACS Applied Nano Materials 2019; 2(10): 6409 doi: 10.1021/acsanm.9b01377
|
| 20 |
Kha Wai Hon, Nadiah Abu, Nurul-Syakima Ab Mutalib, Rahman Jamal. miRNAs and lncRNAs as Predictive Biomarkers of Response to FOLFOX Therapy in Colorectal Cancer. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00846
|
| 21 |
Ali Khalafizadeh, Seyedeh Donya Hashemizadegan, Fatemeh Shokri, Babak Bakhshinejad, Keyvan Jabbari, Mahsa Motavaf, Sadegh Babashah. Competitive endogenous RNA networks: Decoding the role of long non‐coding RNAs and circular RNAs in colorectal cancer chemoresistance. Journal of Cellular and Molecular Medicine 2024; 28(7) doi: 10.1111/jcmm.18197
|
| 22 |
P. Vasudeva Raju, RamaRao Malla. Colon Cancer Diagnosis and Therapy Vol. 3. 2022; : 21 doi: 10.1007/978-3-030-72702-4_2
|
| 23 |
Sameena Gul, Muhammad Faisal Maqbool, Amara Maryam, Muhammad Khan, Hafiz Abdullah Shakir, Muhammad Irfan, Chaman Ara, Yongming Li, Tonghui Ma. Vitamin K: A novel cancer chemosensitizer. Biotechnology and Applied Biochemistry 2022; 69(6): 2641 doi: 10.1002/bab.2312
|
| 24 |
Qingmei Ye, Xin Zhou, Han Ren, Fangxuan Han, Rong Lin, Juan Li. An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1274336
|
| 25 |
Saeedeh Keyvani‐Ghamsari, Khatereh Khorsandi, Asma Gul. Curcumin effect on cancer cells' multidrug resistance: An update. Phytotherapy Research 2020; 34(10): 2534 doi: 10.1002/ptr.6703
|
| 26 |
Folic acid-chitosan functionalized polymeric nanocarriers to treat colon cancer. International Journal of Biological Macromolecules 2023; 253: 127142 doi: 10.1016/j.ijbiomac.2023.127142
|
| 27 |
Zhenyu Xu, Lu Chen, Zhangang Xiao, Yanhong Zhu, Hui Jiang, Yan Jin, Cheng Gu, Yilai Wu, Lin Wang, Wen Zhang, Jian Zuo, Dexi Zhou, Jiajie Luan, Jing Shen. Potentiation of the anticancer effect of doxorubicinin drug-resistant gastric cancer cells by tanshinone IIA. Phytomedicine 2018; 51: 58 doi: 10.1016/j.phymed.2018.05.012
|
| 28 |
Fatemeh Firouzi Amoodizaj, Sevda Baghaeifar, Elham Taheri, Mahdieh Farhoudi Sefidan Jadid, Maryam Safi, Nasrin Seyyed Sani, Saba Hajazimian, Alireza Isazadeh, Dariush Shanehbandi. RETRACTED: Enhanced anticancer potency of doxorubicin in combination with curcumin in gastric adenocarcinoma. Journal of Biochemical and Molecular Toxicology 2020; 34(6) doi: 10.1002/jbt.22486
|
| 29 |
Ninon Very, Tony Lefebvre, Ikram El Yazidi-Belkoura. Drug resistance related to aberrant glycosylation in colorectal cancer. Oncotarget 2018; 9(1): 1380 doi: 10.18632/oncotarget.22377
|
| 30 |
Alessio Carmignani, Matteo Battaglini, Attilio Marino, Francesca Pignatelli, Gianni Ciofani. Drug-Loaded Polydopamine Nanoparticles for Chemo/Photothermal Therapy against Colorectal Cancer Cells. ACS Applied Bio Materials 2024; 7(4): 2205 doi: 10.1021/acsabm.3c01203
|
| 31 |
Yong Yang, Guoxin Wang, Dajian Zhu, Yanfeng Huang, Yong Luo, Pengfei Su, Xiaowu Chen, Qian Wang. Epithelial-mesenchymal transition and cancer stem cell-like phenotype induced by Twist1 contribute to acquired resistance to irinotecan in colon cancer. International Journal of Oncology 2017; 51(2): 515 doi: 10.3892/ijo.2017.4044
|
| 32 |
Dihydropyrimidinones: Recent Synthetic and Pharmacological Perspectives with Special Focus on Colon Cancer. Journal of Pharmaceutical Research and Development 2023; doi: 10.47485/2694-5614.1017
|
| 33 |
Gülçin Yavuz Türel, Nilüfer Şahin Calapoğlu, Dilek Bayram, Meltem Özgöçmen, Vehbi Atahan Toğay, Eda Evgen Tülüceoğlu. Curcumin induces apoptosis through caspase dependent pathway in human colon carcinoma cells. Molecular Biology Reports 2022; 49(2): 1351 doi: 10.1007/s11033-021-06965-y
|
| 34 |
Pandian Sureshbabu Ram Kumar, Clayton Fernando Rencilin, Krishnan Sundar. Emerging nanomaterials for cancer immunotherapy. Exploration of Medicine 2021; 2(3): 208 doi: 10.37349/emed.2021.00043
|
| 35 |
Shoumin Zhu, Shayan Khalafi, Zheng Chen, Julio Poveda, Dunfa Peng, Heng Lu, Mohammed Soutto, Jianwen Que, Monica Garcia-Buitrago, Alexander Zaika, Wael El-Rifai. Silencing of miR490–3p by H. pylori activates DARPP-32 and induces resistance to gefitinib. Cancer Letters 2020; 491: 87 doi: 10.1016/j.canlet.2020.07.014
|
| 36 |
Yongchao Zhang, Zhuo-Xun Wu, Yuqi Yang, Jing-Quan Wang, Jun Li, Zoey Sun, Qiu-Xu Teng, Charles R. Ashby, Dong-Hua Yang. Poziotinib Inhibits the Efflux Activity of the ABCB1 and ABCG2 Transporters and the Expression of the ABCG2 Transporter Protein in Multidrug Resistant Colon Cancer Cells. Cancers 2020; 12(11): 3249 doi: 10.3390/cancers12113249
|
| 37 |
Xiang Li, Nan Wang, Yutong Wu, Yidan Liu, Ruoyu Wang. ALDH6A1 weakens the progression of colon cancer via modulating the RAS/RAF/MEK/ERK pathway in cancer cell lines. Gene 2022; 842: 146757 doi: 10.1016/j.gene.2022.146757
|
| 38 |
Roya Bazzaz, Hossain Bijanpour, Seyed M. B. Pirouzpanah, Parichehreh Yaghmaei, Nadereh Rashtchizadeh. Adjuvant therapy with γ‐tocopherol‐induce apoptosis in HT‐29 colon cancer via cyclin‐dependent cell cycle arrest mechanism. Journal of Biochemical and Molecular Toxicology 2019; 33(11) doi: 10.1002/jbt.22399
|
| 39 |
Batool Fatima, Maryam Jamil, Dilshad Hussain, Adeela Saeed, Fahmida Jabeen, Muhammad Salman Sajid, Muhammad Najam-ul-Haq. Biochemistry of Drug Resistance. 2021; : 367 doi: 10.1007/978-3-030-76320-6_13
|
| 40 |
Li-Li Yang, Meng Li, Wei Huang, Peng-Tao Ren, Qing-Hui Yan, Ying-Hao Hao. ANP32B promotes colorectal cancer cell progression and reduces cell sensitivity to PRAP1 inhibitor through up-regulating HPF1. Heliyon 2024; 10(1): e23829 doi: 10.1016/j.heliyon.2023.e23829
|
| 41 |
Zheng Yang, Zhengye Liu, Mourboul Ablise, Aikebaier Maimaiti, Aizitiaili Aihaiti, Yusupuwajimu Alimujiang. Design and Synthesis of Novel α-Methylchalcone Derivatives, Anti-Cervical Cancer Activity, and Reversal of Drug Resistance in HeLa/DDP Cells. Molecules 2023; 28(23): 7697 doi: 10.3390/molecules28237697
|
| 42 |
Ankur Sood, Aastha Gupta, Ravi Bharadwaj, Pavana Ranganath, Neal Silverman, Garima Agrawal. Biodegradable disulfide crosslinked chitosan/stearic acid nanoparticles for dual drug delivery for colorectal cancer. Carbohydrate Polymers 2022; 294: 119833 doi: 10.1016/j.carbpol.2022.119833
|
| 43 |
Hedayat Hosseini, Amin Abbasi, Sahar Sabahi, Sousan Akrami, Arshid Yousefi-Avarvand. Assessing the Potential Biological Activities of Postbiotics Derived from Saccharomyces cerevisiae: An In Vitro Study. Probiotics and Antimicrobial Proteins 2023; doi: 10.1007/s12602-023-10117-y
|
| 44 |
Janusz Matuszyk. MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy. Molecular Medicine 2022; 28(1) doi: 10.1186/s10020-022-00516-2
|
| 45 |
Borong Zhou, Zhongchao Mai, Ying Ye, Yanan Song, Miao Zhang, Xinlin Yang, Wei Xia, Xiaofeng Qiu. The role of PYCR1 in inhibiting 5-fluorouracil-induced ferroptosis and apoptosis through SLC25A10 in colorectal cancer. Human Cell 2022; 35(6): 1900 doi: 10.1007/s13577-022-00775-5
|
| 46 |
Xiaoke Gu, Yanfei Jiang, Yingying Qu, Jing Chen, Dingding Feng, Chenglin Li, Xiaoxing Yin. Synthesis and biological evaluation of bifendate derivatives bearing 6,7-dihydro-dibenzo[ c,e ]azepine scaffold as potential P-glycoprotein and tumor metastasis inhibitors. European Journal of Medicinal Chemistry 2018; 145: 379 doi: 10.1016/j.ejmech.2018.01.019
|
| 47 |
Monu Kumar Kashyap, Akash Ved, Rajiv Ratan Singh Yadav, Akhand Pratap Singh, Mahima Kushwaha, Karuna S. Shukla. The Cell Death and Signal Transduction Mechanisms in Colorectal Carcinogenesis:
Recent Advances. Anti-Cancer Agents in Medicinal Chemistry 2023; 23(12): 1361 doi: 10.2174/1871520623666230328144748
|
| 48 |
Steven Forsythe, Naren Mehta, Mahesh Devarasetty, Hemamylammal Sivakumar, William Gmeiner, Shay Soker, Konstantinos Votanopoulos, Aleksander Skardal. Development of a Colorectal Cancer 3D Micro-tumor Construct Platform From Cell Lines and Patient Tumor Biospecimens for Standard-of-Care and Experimental Drug Screening. Annals of Biomedical Engineering 2020; 48(3): 940 doi: 10.1007/s10439-019-02269-2
|
| 49 |
Sanaz Naghizadeh, Behzad Mansoori, Ali Mohammadi, Ebrahim Sakhinia , Behzad Baradaran. Gene Silencing Strategies in Cancer Therapy: An Update for Drug Resistance. Current Medicinal Chemistry 2019; 26(34): 6282 doi: 10.2174/0929867325666180403141554
|
| 50 |
Xitong Su, Lei Wu, Mingming Hu, Wenxiang Dong, Meng Xu, Peng Zhang. Glycyrrhizic acid: A promising carrier material for anticancer therapy. Biomedicine & Pharmacotherapy 2017; 95: 670 doi: 10.1016/j.biopha.2017.08.123
|
| 51 |
Siddarth Agrawal, Marta Woźniak, Mateusz Łuc, Sebastian Makuch, Ewa Pielka, Anil Kumar Agrawal, Joanna Wietrzyk, Joanna Banach, Andrzej Gamian, Monika Pizon, Piotr Ziółkowski. Insulin enhancement of the antitumor activity of chemotherapeutic agents in colorectal cancer is linked with downregulating PIK3CA and GRB2. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53145-x
|
| 52 |
Chao Yang, Shuoyang Huang, Fengyu Cao, Yongbin Zheng. Role of ferroptosis-related genes in prognostic prediction and tumor immune microenvironment in colorectal carcinoma. PeerJ 2021; 9: e11745 doi: 10.7717/peerj.11745
|
| 53 |
Ming‑Zhen Wang, Cheng‑Zhi Qiu, Wai‑Shi Yu, Yan‑Ta Guo, Chun‑Xiao Wang, Zhi‑Xiong Chen. GOLPH3 expression promotes the resistance of HT29 cells to 5‑fluorouracil by activating multiple signaling pathways. Molecular Medicine Reports 2017; doi: 10.3892/mmr.2017.7877
|
| 54 |
Zhiming Shan, Na An, Jielin Qin, Junmei Yang, Hongqi Sun, Wei Yang. Long non-coding RNA Linc00675 suppresses cell proliferation and metastasis in colorectal cancer via acting on miR-942 and Wnt/β-catenin signaling. Biomedicine & Pharmacotherapy 2018; 101: 769 doi: 10.1016/j.biopha.2018.02.123
|
| 55 |
Korosh Morshedi, Sarina Borran, Mohammad Saeid Ebrahimi, Mohammad Jaber Masoud khooy, Zeynab Sadat Seyedi, Atefeh Amiri, Mohammad Abbasi‐Kolli, Maryam Fallah, Haroon Khan, Amirhossein Sahebkar, Hamed Mirzaei. Therapeutic effect of curcumin in gastrointestinal cancers: A comprehensive review. Phytotherapy Research 2021; 35(9): 4834 doi: 10.1002/ptr.7119
|
| 56 |
Dongxin Tang, Zhu Yang, Fengxi Long, Li Luo, Bing Yang, Ruyi Zhu, Xianan Sang, Gang Cao. Inhibition of MALAT1 reduces tumor growth and metastasis and promotes drug sensitivity in colorectal cancer. Cellular Signalling 2019; 57: 21 doi: 10.1016/j.cellsig.2019.01.013
|
| 57 |
Sona Vodenkova, Tomas Buchler, Klara Cervena, Veronika Veskrnova, Pavel Vodicka, Veronika Vymetalkova. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future. Pharmacology & Therapeutics 2020; 206: 107447 doi: 10.1016/j.pharmthera.2019.107447
|
| 58 |
Sara Cherradi, Véronique Garambois, Johanna Marines, Augusto Faria Andrade, Alexandra Fauvre, Olivia Morand, Manon Fargal, Ferial Mancouri, Adeline Ayrolles-Torro, Nadia Vezzo-Vié, Marta Jarlier, Gerald Loussaint, Steve Huvelle, Nicolas Joubert, Thibault Mazard, Céline Gongora, Philippe Pourquier, Florence Boissière-Michot, Maguy Del Rio. Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells. Cell & Bioscience 2023; 13(1) doi: 10.1186/s13578-023-01015-5
|
| 59 |
Jesica M. Ramírez-Villalobos, César I. Romo-Sáenz, Karla S. Morán-Santibañez, Patricia Tamez-Guerra, Ramiro Quintanilla-Licea, Alonso A. Orozco-Flores, Ricardo Romero-Arguelles, Reyes Tamez-Guerra, Cristina Rodríguez-Padilla, Ricardo Gomez-Flores. In Vitro Tumor Cell Growth Inhibition Induced by Lophocereus marginatus (DC.) S. Arias and Terrazas Endophytic Fungi Extracts. International Journal of Environmental Research and Public Health 2021; 18(18): 9917 doi: 10.3390/ijerph18189917
|
| 60 |
Arunaksharan Narayanankutty. PI3K/ Akt/ mTOR Pathway as a Therapeutic Target for Colorectal Cancer: A Review of Preclinical and Clinical Evidence. Current Drug Targets 2019; 20(12): 1217 doi: 10.2174/1389450120666190618123846
|
| 61 |
Shan-Ju Yeh, Shuo-Wei Chen, Bor-Sen Chen. Investigation of the Genome-Wide Genetic and Epigenetic Networks for Drug Discovery Based on Systems Biology Approaches in Colorectal Cancer. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00117
|
| 62 |
Narges Toolabi, Fattane Sam Daliri, Amir Mokhlesi, Mahmood Talkhabi. Identification of key regulators associated with colon cancer prognosis and pathogenesis. Journal of Cell Communication and Signaling 2022; 16(1): 115 doi: 10.1007/s12079-021-00612-8
|
| 63 |
Wanying Liao, Junyu Long, Yiran Li, Fucun Xie, Ziyu Xun, Yanyu Wang, Xu Yang, Yunchao Wang, Kang Zhou, Xinting Sang, Haitao Zhao. Identification of an m6A-Related Long Noncoding RNA Risk Model for Predicting Prognosis and Directing Treatments in Patients With Colon Adenocarcinoma. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.910749
|
| 64 |
Di Wu, Wen-Yi Zhou, Xiao-Tong Lin, Lei Fang, Chuan-Ming Xie. Bufalin induces apoptosis via mitochondrial ROS-mediated caspase-3 activation in HCT-116 and SW620 human colon cancer cells. Drug and Chemical Toxicology 2019; 42(4): 444 doi: 10.1080/01480545.2018.1512611
|
| 65 |
Janet Piloto-Ferrer, Ángel Sánchez-Lamar, Marbelis Francisco, Maria L. González, Nelsón Merino, Guillermo Aparicio, Carlos Pérez, Idania Rodeiro, Miriam Teresa Paz Lopes. Xanthium strumarium´s xanthatins induces mitotic arrest and apoptosis in CT26WT colon carcinoma cells. Phytomedicine 2019; 57: 236 doi: 10.1016/j.phymed.2018.12.019
|
| 66 |
Marta Woźniak, Sebastian Makuch, Kinga Winograd, Jerzy Wiśniewski, Piotr Ziółkowski, Siddarth Agrawal. 6-Shogaol enhances the anticancer effect of 5-fluorouracil, oxaliplatin, and irinotecan via increase of apoptosis and autophagy in colon cancer cells in hypoxic/aglycemic conditions. BMC Complementary Medicine and Therapies 2020; 20(1) doi: 10.1186/s12906-020-02913-8
|
| 67 |
Susmita Ghosh, Fan Fan, Reid T. Powell, Jason Roszik, Yong Sung Park, Clifford Stephan, Manu Sebastian, Lin Tan, Alexey V. Sorokin, Philip L. Lorenzi, Scott Kopetz, Lee M. Ellis, Rajat Bhattacharya. Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer. Molecular Cancer Therapeutics 2023; 22(8): 962 doi: 10.1158/1535-7163.MCT-23-0110
|
| 68 |
Ming Hu, Xiandong Fu, Zhaoming Si, Chunming Li, Jihu Sun, Xinna Du, Hu Zhang. Identification of Differently Expressed Genes Associated With Prognosis and Growth in Colon Adenocarcinoma Based on Integrated Bioinformatics Analysis. Frontiers in Genetics 2019; 10 doi: 10.3389/fgene.2019.01245
|
| 69 |
Hang Li, Shaohong Lu, Yu Chen, Longzhi Zheng, Liangyuan Chen, Haojie Ding, Jianzu Ding, Di Lou, Fangfang Liu, Bin Zheng. AKT2 phosphorylation of hexokinase 2 at T473 promotes tumorigenesis and metastasis in colon cancer cells via NF-κB, HIF1α, MMP2, and MMP9 upregulation. Cellular Signalling 2019; 58: 99 doi: 10.1016/j.cellsig.2019.03.011
|
| 70 |
Md. Sanower Hossain, Hidayah Karuniawati, Ammar Abdulrahman Jairoun, Zannat Urbi, Der Jiun Ooi, Akbar John, Ya Chee Lim, K. M. Kaderi Kibria, A.K. M. Mohiuddin, Long Chiau Ming, Khang Wen Goh, Muhammad Abdul Hadi. Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies. Cancers 2022; 14(7): 1732 doi: 10.3390/cancers14071732
|
| 71 |
Rafael Moreno-Sánchez, Álvaro Marín-Hernández, Juan C. Gallardo-Pérez, Silvia C. Pacheco-Velázquez, Diana X. Robledo-Cadena, Joaquín Alberto Padilla-Flores, Emma Saavedra, Sara Rodríguez-Enríquez. Physiological Role of Glutamate Dehydrogenase in Cancer Cells. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00429
|
| 72 |
Keisuke Okuno, Muhammad Yogi Pratama, Jiang Li, Masanori Tokunaga, Xin Wang, Yusuke Kinugasa, Ajay Goel. Ginseng mediates its anticancer activity by inhibiting the expression of DNMTs and reactivating methylation-silenced genes in colorectal cancer. Carcinogenesis 2023; 44(5): 394 doi: 10.1093/carcin/bgad025
|
| 73 |
Tyler S. Larson, Gary L. Glish, Matthew R. Lockett. Spatially resolved quantification of drug metabolism and efficacy in 3D paper-based tumor mimics. Analytica Chimica Acta 2021; 1186: 339091 doi: 10.1016/j.aca.2021.339091
|
| 74 |
Yushan Mao, Hanhan Xie, Dan Shu, Lin Cheng, Jingbin Lan, Kejian Pan. Moxidectin induces autophagy arrest in colorectal cancer. Medical Oncology 2022; 39(12) doi: 10.1007/s12032-022-01799-5
|
| 75 |
Yi Ji, Jialin Gu, Hongqun Zhang, Houxi Xu. Identification and Validation of Key miRNAs for Colon Cancer Based on miRNA-Gene Integration Analysis. International Journal of General Medicine 2023; : 5703 doi: 10.2147/IJGM.S440340
|
| 76 |
Arka Jyoti Chakraborty, Tanvir Mahtab Uddin, B. M. Redwan Matin Zidan, Saikat Mitra, Rajib Das, Firzan Nainu, Kuldeep Dhama, Arpita Roy, Md. Jamal Hossain, Ameer Khusro, Talha Bin Emran, Ruchika Garg. Allium cepa: A Treasure of Bioactive Phytochemicals with Prospective Health Benefits. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/4586318
|
| 77 |
Bishu Zhang, Jiewei Lin, Jiaqiang Zhang, Xuelong Wang, Xiaxing Deng. Integrated Chromatin Accessibility and Transcriptome Landscapes of 5-Fluorouracil-Resistant Colon Cancer Cells. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.838332
|
| 78 |
Jaeok Lee, Jiyeon Kang, Na-Yun Kwon, Aneesh Sivaraman, Ravi Naik, So-Young Jin, A. Reum Oh, Jae-Ho Shin, Younghwa Na, Kyeong Lee, Hwa-Jeong Lee. Dual Inhibition of P-gp and BCRP Improves Oral Topotecan Bioavailability in Rodents. Pharmaceutics 2021; 13(4): 559 doi: 10.3390/pharmaceutics13040559
|
| 79 |
Rukeia El-Athman, Luise Fuhr, Angela Relógio. A Systems-Level Analysis Reveals Circadian Regulation of Splicing in Colorectal Cancer. EBioMedicine 2018; 33: 68 doi: 10.1016/j.ebiom.2018.06.012
|
| 80 |
Mohammed Tanveer Ahmed, Sampa Sarkar, Ravi Shukla, Rajkumar Banerjee. Etoposide‐Entrapped Progesterone‐Cationic Lipid Nanoaggregates as Selective Therapeutics against Etoposide‐Resistant Colorectal Cancer Cells. ChemBioChem 2023; 24(12) doi: 10.1002/cbic.202200650
|
| 81 |
Laura Ioana Gavrilas, Daniel Cruceriu, Andrei Mocan, Felicia Loghin, Doina Miere, Ovidiu Balacescu. Plant-Derived Bioactive Compounds in Colorectal Cancer: Insights from Combined Regimens with Conventional Chemotherapy to Overcome Drug-Resistance. Biomedicines 2022; 10(8): 1948 doi: 10.3390/biomedicines10081948
|
| 82 |
Agustina Tri Endharti, Yeni Purnamasari, Renata Primasari, Sri Poeranto, Sofy Permana. Coelomic Fluid of Lumbricus rubellus Synergistically Enhances Cytotoxic Effect of 5-Fluorouracil through Modulation of Focal Adhesion Kinase and p21 in HT-29 Cancer Cell Line. The Scientific World Journal 2019; 2019: 1 doi: 10.1155/2019/5632859
|
| 83 |
Kinga Oravetz, Adelina-Violeta Todea, Ovidiu Balacescu, Daniel Cruceriu, Elena Rakosy-Tican. Potential antitumor activity of garlic against colorectal cancer: focus on the molecular mechanisms of action. European Journal of Nutrition 2023; 62(6): 2347 doi: 10.1007/s00394-023-03166-0
|
| 84 |
Yeelon Yeoh, Teck Yew Low, Nadiah Abu, Pey Yee Lee. Regulation of signal transduction pathways in colorectal cancer: implications for therapeutic resistance. PeerJ 2021; 9: e12338 doi: 10.7717/peerj.12338
|
| 85 |
Jie Zhang , Qianqian Song, Mengna Wu, Wenjie Zheng. The Emerging Roles of Exosomes in the Chemoresistance of Hepatocellular Carcinoma. Current Medicinal Chemistry 2020; 28(1): 93 doi: 10.2174/0929867327666200130103206
|
| 86 |
Mei Sun, Xiang Tian, Zhibo Yang. Microscale Mass Spectrometry Analysis of Extracellular Metabolites in Live Multicellular Tumor Spheroids. Analytical Chemistry 2017; 89(17): 9069 doi: 10.1021/acs.analchem.7b01746
|
| 87 |
Yaiza Jiménez-Martínez, Carmen Griñán-Lisón, Hoda Khaldy, Ana Martín, Alba Cambrils, Andrea Ibáñez Grau, Gema Jiménez, Juan A. Marchal, Houria Boulaiz. LdrB Toxin with In Vitro and In Vivo Antitumor Activity as a Potential Tool for Cancer Gene Therapy. Cancers 2019; 11(7): 1016 doi: 10.3390/cancers11071016
|
| 88 |
Dan Wang, Li Yang, Weina Yu, Qian Wu, Jingyao Lian, Feng Li, Shasha Liu, Aitian Li, Zhiang He, Jinbo Liu, Zhenqiang Sun, Weitang Yuan, Yi Zhang. Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling. Journal for ImmunoTherapy of Cancer 2019; 7(1) doi: 10.1186/s40425-019-0701-2
|
| 89 |
Musbau Adewumi Akanji, Heritage Demilade Fatinukun, Damilare Emmanuel Rotimi, Boluwatife Lawrence Afolabi, Oluyomi Stephen Adeyemi. Antioxidants - Benefits, Sources, Mechanisms of Action. 2021; doi: 10.5772/intechopen.94988
|
| 90 |
Hyeon-Hui Ki, Ji-Hyun Lee, Hoon-Yeon Lee, Young-Mi Lee, Dae-Ki Kim. Triticum aestivumSprouts Extract Inhibits Azoymethane (AOM)/Dextran Sodium Sulfate (DSS)-Induced Colon Carcinogenesis in Mice. Nutrition and Cancer 2018; 70(6): 928 doi: 10.1080/01635581.2018.1490447
|
| 91 |
Guangyi Liu, Huan Wang, Rui Ran, Yicheng Wang, Yang Li. FOSL1 transcriptionally regulates PHLDA2 to promote 5-FU resistance in colon cancer cells. Pathology - Research and Practice 2023; 246: 154496 doi: 10.1016/j.prp.2023.154496
|
| 92 |
Lichao Zhang, Xiaoqing Lu, Yuanzhi Xu, Xiaoqin La, Jinmiao Tian, Aiping Li, Hanqing Li, Changxin Wu, Yanfeng Xi, Guisheng Song, Zhaocai Zhou, Wenqi Bai, Liwei An, Zhuoyu Li. Tumor-associated macrophages confer colorectal cancer 5-fluorouracil resistance by promoting MRP1 membrane translocation via an intercellular CXCL17/CXCL22–CCR4–ATF6–GRP78 axis. Cell Death & Disease 2023; 14(9) doi: 10.1038/s41419-023-06108-0
|
| 93 |
Xiao‑Yun Li, Xiao‑Feng Liao, Hong‑Bo Wang, Jian Zhang. Doxorubicin resistance induces IL6 activation in the colon cancer cell line LS180. Oncology Letters 2018; doi: 10.3892/ol.2018.9360
|
| 94 |
Ana Luiza C. de S. L. Oliveira, Raimundo Fernandes de Araújo Júnior, Thaís Gomes de Carvalho, Alan B. Chan, Timo Schomann, Filippo Tamburini, Lioe-Fee de Geus-Oei, Luis J. Cruz. Effect of Oxaliplatin-Loaded Poly (d,l-Lactide-co-Glycolic Acid) (PLGA) Nanoparticles Combined with Retinoic Acid and Cholesterol on Apoptosis, Drug Resistance, and Metastasis Factors of Colorectal Cancer. Pharmaceutics 2020; 12(2): 193 doi: 10.3390/pharmaceutics12020193
|
| 95 |
Zi‐Ning Lei, Qiu‐Xu Teng, Zhuo‐Xun Wu, Feng‐Feng Ping, Peng Song, John N.D. Wurpel, Zhe‐Sheng Chen. Overcoming multidrug resistance by knockout of ABCB1 gene using CRISPR/Cas9 system in SW620/Ad300 colorectal cancer cells. MedComm 2021; 2(4): 765 doi: 10.1002/mco2.106
|
| 96 |
Chao Chen, Lu Lu, Shichao Yan, Huimei Yi, Hui Yao, Di Wu, Guangchun He, Xiaojun Tao, Xiyun Deng. Autophagy and doxorubicin resistance in cancer. Anti-Cancer Drugs 2018; 29(1): 1 doi: 10.1097/CAD.0000000000000572
|
| 97 |
Cordula Stillhart, Katarina Vučićević, Patrick Augustijns, Abdul W. Basit, Hannah Batchelor, Talia R. Flanagan, Ina Gesquiere, Rick Greupink, Daniel Keszthelyi, Mikko Koskinen, Christine M. Madla, Christophe Matthys, Goran Miljuš, Miriam G. Mooij, Neil Parrott, Anna-Lena Ungell, Saskia N. de Wildt, Mine Orlu, Sandra Klein, Anette Müllertz. Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review. European Journal of Pharmaceutical Sciences 2020; 147: 105280 doi: 10.1016/j.ejps.2020.105280
|
| 98 |
Yun Luo, Chong-Zhi Wang, Richard Sawadogo, Jinbin Yuan, Jinxiang Zeng, Ming Xu, Ting Tan, Chun-Su Yuan. 4-Vinylguaiacol, an Active Metabolite of Ferulic Acid by Enteric Microbiota and Probiotics, Possesses Significant Activities against Drug-Resistant Human Colorectal Cancer Cells. ACS Omega 2021; 6(7): 4551 doi: 10.1021/acsomega.0c04394
|
| 99 |
Yinghui Huang, Huiqian Huang, Yong Wang, Hui Liu, Yingdan Huang. 5mC-Related lncRNAs as Potential Prognostic Biomarkers in Colon Adenocarcinoma. Biology 2022; 11(2): 231 doi: 10.3390/biology11020231
|
| 100 |
Lubna Siddiqui, Nazeer Hasan, Pawan K. Mishra, Neha Gupta, Anu T. Singh, Alka Madaan, Manu Jaggi, Suma Saad, Adam Ekielski, Zeenat Iqbal, Prashant Kesharwani, Sushama Talegaonkar. CD44 mediated colon cancer targeting mutlifaceted lignin nanoparticles: Synthesis, in vitro characterization and in vivo efficacy studies. International Journal of Pharmaceutics 2023; 643: 123270 doi: 10.1016/j.ijpharm.2023.123270
|
| 101 |
Xing-Hua Zhou, Jian Kang, Zhen-Dong Zhong, Yue Cheng. Osthole induces apoptosis of the HT‑29 cells via endoplasmic reticulum stress and autophagy. Oncology Letters 2021; 22(4) doi: 10.3892/ol.2021.12987
|
| 102 |
Samar Al Bitar, Marwan El-Sabban, Samer Doughan, Wassim Abou-Kheir. Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond. World Journal of Gastroenterology 2023; 29(9): 1395-1426 doi: 10.3748/wjg.v29.i9.1395
|
| 103 |
Chien-Yu Huang, Po-Li Wei, Uyanga Batzorig, Precious Takondwa Makondi, Cheng-Chin Lee, Yu-Jia Chang. Identification of Moesin (MSN) as a Potential Therapeutic Target for Colorectal Cancer via the β-Catenin-RUNX2 Axis. International Journal of Molecular Sciences 2023; 24(13): 10951 doi: 10.3390/ijms241310951
|
| 104 |
Cheng Chen, Ana Beloqui, Yining Xu. Oral nanomedicine biointeractions in the gastrointestinal tract in health and disease. Advanced Drug Delivery Reviews 2023; 203: 115117 doi: 10.1016/j.addr.2023.115117
|
| 105 |
Zhiwen Li, Xu Zhou, Huaqiang Zhu, Xie Song, Hengjun Gao, Zheyu Niu, Jun Lu. Purpurin binding interacts with LHPP protein that inhibits PI3K/AKT phosphorylation and induces apoptosis in colon cancer cells HCT‐116. Journal of Biochemical and Molecular Toxicology 2021; 35(3) doi: 10.1002/jbt.22665
|
| 106 |
Jinjin Chu, Xianzhu Fang, Zhonghou Sun, Linlin Gai, Wenqing Dai, Haibo Li, Xinyi Yan, Jinke Du, Lili Zhang, Lu Zhao, Donghua Xu, Shushan Yan. Non-Coding RNAs Regulate the Resistance to Anti-EGFR Therapy in Colorectal Cancer. Frontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.801319
|
| 107 |
Marloes Zoetemelk, George M. Ramzy, Magdalena Rausch, Thibaud Koessler, Judy R. van Beijnum, Andrea Weiss, Valentin Mieville, Sander R. Piersma, Richard R. de Haas, Céline Delucinge‐Vivier, Axel Andres, Christian Toso, Alexander A. Henneman, Simone Ragusa, Tatiana V. Petrova, Mylène Docquier, Thomas A. McKee, Connie R. Jimenez, Youssef Daali, Arjan W. Griffioen, Laura Rubbia‐Brandt, Pierre‐Yves Dietrich, Patrycja Nowak‐Sliwinska. Optimized low‐dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment. Molecular Oncology 2020; 14(11): 2894 doi: 10.1002/1878-0261.12797
|
| 108 |
Francisco Quiñonero, Cristina Mesas, Mercedes Peña, Laura Cabeza, Gloria Perazzoli, Consolación Melguizo, Raul Ortiz, Jose Prados. Vegetal-Derived Bioactive Compounds as Multidrug Resistance Modulators in Colorectal Cancer. Applied Sciences 2023; 13(4): 2667 doi: 10.3390/app13042667
|
| 109 |
Anshul Panjeta, Simran Preet. Anticancer potential of human intestinal defensin 5 against 1, 2-dimethylhydrazine dihydrochloride induced colon cancer: A therapeutic approach. Peptides 2020; 126: 170263 doi: 10.1016/j.peptides.2020.170263
|
| 110 |
Nada K. Sedky, Iten M. Fawzy, Afnan Hassan, Noha Khalil Mahdy, Reem T. Attia, Samir N. Shamma, Mohammad Y. Alfaifi, Serag Eldin Elbehairi, Fatma A. Mokhtar, Sherif Ashraf Fahmy. Innovative microwave-assisted biosynthesis of copper oxide nanoparticles loaded with platinum(ii) based complex for halting colon cancer: cellular, molecular, and computational investigations. RSC Advances 2024; 14(6): 4005 doi: 10.1039/D3RA08779D
|
| 111 |
Koniyan Shaheer, HM Somashekarappa, M. Divya Lakshmanan. Piperine sensitizes radiation‐resistant cancer cells towards radiation and promotes intrinsic pathway of apoptosis. Journal of Food Science 2020; 85(11): 4070 doi: 10.1111/1750-3841.15496
|
| 112 |
Junsha An, Cheng Peng, Hailin Tang, Xiuxiu Liu, Fu Peng. New Advances in the Research of Resistance to Neoadjuvant Chemotherapy in Breast Cancer. International Journal of Molecular Sciences 2021; 22(17): 9644 doi: 10.3390/ijms22179644
|
| 113 |
Arunaksharan Narayanankutty, Sreelakshmi Nambiattil, Sreeshna Mannarakkal. Phytochemicals and Nanoparticles in the Modulation of PI3K/Akt/mTOR
Kinases and its Implications in the Development and Progression of Gastrointestinal
Cancers: A Review of Preclinical and Clinical Evidence. Recent Patents on Anti-Cancer Drug Discovery 2023; 18(3): 307 doi: 10.2174/1574892817666220606104712
|
| 114 |
Julita Kulbacka, Nina Rembiałkowska, Anna Szewczyk, Helena Moreira, Anna Szyjka, Irutė Girkontaitė, Kamil P. Grela, Vitalij Novickij. The Impact of Extracellular Ca2+ and Nanosecond Electric Pulses on Sensitive and Drug-Resistant Human Breast and Colon Cancer Cells. Cancers 2021; 13(13): 3216 doi: 10.3390/cancers13133216
|
| 115 |
Atul Sudame, Ganeshlenin Kandasamy, Deepak Singh, C.V. Tomy, Dipak Maity. Symbiotic thermo-chemotherapy for enhanced HepG2 cancer treatment via magneto-drugs encapsulated polymeric nanocarriers. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2020; 606: 125355 doi: 10.1016/j.colsurfa.2020.125355
|
| 116 |
Yan-Jie Xu, Jie-Min Zhao, Cao Gao, Xue-Feng Ni, Wei Wang, Wen-Wei Hu, Chang-Ping Wu. Hsa_circ_0136666 activates Treg-mediated immune escape of colorectal cancer via miR-497/PD-L1 pathway. Cellular Signalling 2021; 86: 110095 doi: 10.1016/j.cellsig.2021.110095
|
| 117 |
Lubna Siddiqui, Harshita Mishra, Pawan Kumar Mishra, Zeenat Iqbal, Sushama Talegaonkar. Novel 4-in-1 strategy to combat colon cancer, drug resistance and cancer relapse utilizing functionalized bioinspiring lignin nanoparticle. Medical Hypotheses 2018; 121: 10 doi: 10.1016/j.mehy.2018.09.003
|
| 118 |
Mark Primeaux, Xiangdong Liu, Saiprasad Gowrikumar, Iram Fatima, Kurt W. Fisher, Dhundy Bastola, Alex J. Vecchio, Amar B. Singh, Punita Dhawan. Claudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in colorectal cancer. Cancer Letters 2023; 579: 216479 doi: 10.1016/j.canlet.2023.216479
|
| 119 |
Iram Fatima, Rizwan Ahmad, Susmita Barman, Saiprasad Gowrikumar, Kristina Pravoverov, Mark Primeaux, Kurt W. Fisher, Amar B. Singh, Punita Dhawan. Albendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF20. British Journal of Cancer 2024; 130(6): 1046 doi: 10.1038/s41416-023-02570-x
|
| 120 |
Chih Kit Chung, Jomarien García-Couce, Yaima Campos, Dana Kralisch, Katja Bierau, Alan Chan, Ferry Ossendorp, Luis Javier Cruz. Doxorubicin Loaded Poloxamer Thermosensitive Hydrogels: Chemical, Pharmacological and Biological Evaluation. Molecules 2020; 25(9): 2219 doi: 10.3390/molecules25092219
|
| 121 |
Yongxi Zhang, Huijie Jia, Zhiang Liu, Jing Guo, Yang Li, Ruipeng Li, Gaozan Zhu, Jie Li, Minjie Li, Xinyi Li, Shenggen Wang, Chengxue Dang, Tiesuo Zhao. D-MT prompts the anti-tumor effect of oxaliplatin by inhibiting IDO expression in a mouse model of colon cancer. International Immunopharmacology 2021; 101: 108203 doi: 10.1016/j.intimp.2021.108203
|
| 122 |
Helena A. Herrmann, Mate Rusz, Dina Baier, Michael A. Jakupec, Bernhard K. Keppler, Walter Berger, Gunda Koellensperger, Jürgen Zanghellini. Thermodynamic Genome-Scale Metabolic Modeling of Metallodrug Resistance in Colorectal Cancer. Cancers 2021; 13(16): 4130 doi: 10.3390/cancers13164130
|
| 123 |
Yiliu Chen, Shengsuo Ma, Dajin Pi, Yingchao Wu, Qian Zuo, Chongan Li, Mingzi Ouyang. Luteolin induces pyroptosis in HT-29 cells by activating the Caspase1/Gasdermin D signalling pathway. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.952587
|
| 124 |
Tony R. Reid, Nacer Abrouk, Scott Caroen, Bryan Oronsky, Meaghan Stirn, Christopher Larson, Keola Beale, Susan J. Knox, George Fisher. ROCKET: Phase II Randomized, Active-controlled, Multicenter Trial to Assess the Safety and Efficacy of RRx-001 + Irinotecan vs. Single-agent Regorafenib in Third/Fourth Line Colorectal Cancer. Clinical Colorectal Cancer 2023; 22(1): 92 doi: 10.1016/j.clcc.2022.11.003
|
| 125 |
Wei-Liang Cui, Dong-Xiao Guo, Ning Wang, Zhi-Fan Wang, Jian-Bo Ji, Xiao Wang, Chun-Guo Yang, Yong-Qiang Lin, Shu-Qi Wang. Identification of chemosensitizing agents of colorectal cancer in Rauvolfia vomitoria using an NMR-based chemometric approach. Frontiers in Chemistry 2023; 10 doi: 10.3389/fchem.2022.1069591
|
| 126 |
Jiehui Cai, Xinkang Zhang, Wanchun Xie, Zhiyang Li, Wei Liu, An Liu. Identification of a basement membrane-related gene signature for predicting prognosis and estimating the tumor immune microenvironment in breast cancer. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1065530
|
| 127 |
Mahdieh Farhoudi Sefidan Jadid, Elnaz Aghaei, Elham Taheri, Nasrin Seyyedsani, Reza Chavoshi, Samane Abbasi, Afshin Khorrami, Pouya Goleij, Saba Hajazimian, Sina Taefehshokr, Alireza Isazadeh, Dariush Shanehbandi. Melatonin increases the anticancer potential of doxorubicin in Caco‐2 colorectal cancer cells. Environmental Toxicology 2021; 36(6): 1061 doi: 10.1002/tox.23105
|
| 128 |
Farbod Bahreini, Nima Rezaei. Handbook of Cancer and Immunology. 2023; : 1 doi: 10.1007/978-3-030-80962-1_336-1
|
| 129 |
Debasish Kumar Dey, Himanshi Gahlot, Sukkum Ngullie Chang, Sun Chul Kang. CopA3 treatment suppressed multidrug resistivity in HCT-116 cell line by p53-induced degradation of hypoxia-inducible factor 1α. Life Sciences 2023; 329: 121933 doi: 10.1016/j.lfs.2023.121933
|
| 130 |
Tao Liu, Rongmu Xia, Chenmeng Li, Xiaocong Chen, Xuemin Cai, Wengang Li. mRNA expression level of CDH2, LEP, POSTN, TIMP1 and VEGFC modulates 5‑fluorouracil resistance in colon cancer cells. Experimental and Therapeutic Medicine 2021; 22(3) doi: 10.3892/etm.2021.10455
|
| 131 |
Andrzej Kubiak, Matteo Chighizola, Carsten Schulte, Natalia Bryniarska, Julita Wesołowska, Maciej Pudełek, Małgorzata Lasota, Damian Ryszawy, Agnieszka Basta-Kaim, Piotr Laidler, Alessandro Podestà, Małgorzata Lekka. Stiffening of DU145 prostate cancer cells driven by actin filaments – microtubule crosstalk conferring resistance to microtubule-targeting drugs. Nanoscale 2021; 13(12): 6212 doi: 10.1039/D0NR06464E
|
| 132 |
Xingkang Wu, Yuemao Shen. PMN inhibits colorectal cancer cells through inducing mitotic arrest and p53-dependent apoptosis via the inhibition of tubulin polymerization. Biochemical and Biophysical Research Communications 2018; 499(4): 927 doi: 10.1016/j.bbrc.2018.04.021
|
| 133 |
Veronika Skarkova, Vera Kralova, Barbora Vitovcova, Emil Rudolf. Selected Aspects of Chemoresistance Mechanisms in Colorectal Carcinoma—A Focus on Epithelial-to-Mesenchymal Transition, Autophagy, and Apoptosis. Cells 2019; 8(3): 234 doi: 10.3390/cells8030234
|
| 134 |
Hao Lin, Liang Zhang, Caihua Zhang, Pengpeng Liu. Exosomal MiR‐500a‐3p promotes cisplatin resistance and stemness via negatively regulating FBXW7 in gastric cancer. Journal of Cellular and Molecular Medicine 2020; 24(16): 8930 doi: 10.1111/jcmm.15524
|
| 135 |
Sonia Trombino, Simona Serini, Roberta Cassano, Gabriella Calviello. Xanthan gum-based materials for omega-3 PUFA delivery: Preparation, characterization and antineoplastic activity evaluation. Carbohydrate Polymers 2019; 208: 431 doi: 10.1016/j.carbpol.2019.01.001
|
| 136 |
N.A. Bhaskaran, L. Kumar. Treating colon cancers with a non-conventional yet strategic approach: An overview of various nanoparticulate systems. Journal of Controlled Release 2021; 336: 16 doi: 10.1016/j.jconrel.2021.06.008
|
| 137 |
Daiki Kikuchi, Motonobu Saito, Katsuharu Saito, Yohei Watanabe, Yoshiko Matsumoto, Yasuyuki Kanke, Hisashi Onozawa, Suguru Hayase, Wataru Sakamoto, Teruhide Ishigame, Tomoyuki Momma, Shinji Ohki, Seiichi Takenoshita. Upregulated solute carrier family 37 member 1 in colorectal cancer is associated with poor patient outcome and metastasis. Oncology Letters 2017; doi: 10.3892/ol.2017.7559
|
| 138 |
Haijun Wang, Jia Liu, Jinsong Li, Dan Zang, Xiaohui Wang, Yiyang Chen, Tengteng Gu, Wei Su, Na Song. Identification of gene modules and hub genes in colon adenocarcinoma associated with pathological stage based on WGCNA analysis. Cancer Genetics 2020; 242: 1 doi: 10.1016/j.cancergen.2020.01.052
|
| 139 |
Vugar Yagublu, Bayram Bayramov, Christoph Reissfelder, Javahir Hajibabazade, Shalala Abdulrahimli, Michael Keese. Microarray-based detection and expression analysis of drug resistance in an animal model of peritoneal metastasis from colon cancer. Clinical & Experimental Metastasis 2024; doi: 10.1007/s10585-024-10283-5
|
| 140 |
Negar Moradian, Nima Rezaei. Handbook of Cancer and Immunology. 2023; : 1 doi: 10.1007/978-3-030-80962-1_197-1
|
| 141 |
Chi Hin Cho, Tao Hu. Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies. 2020; : xiii doi: 10.1016/B978-0-12-819937-4.09995-7
|
| 142 |
Junyi Ren, Bo Wang, Qifeng Wu, Guiling Wang. Combination of niclosamide and current therapies to overcome resistance for cancer: New frontiers for an old drug. Biomedicine & Pharmacotherapy 2022; 155: 113789 doi: 10.1016/j.biopha.2022.113789
|
| 143 |
Richard Jennemann, Martina Volz, Felix Bestvater, Claudia Schmidt, Karsten Richter, Sylvia Kaden, Johannes Müthing, Hermann-Josef Gröne, Roger Sandhoff. Blockade of Glycosphingolipid Synthesis Inhibits Cell Cycle and Spheroid Growth of Colon Cancer Cells In Vitro and Experimental Colon Cancer Incidence In Vivo. International Journal of Molecular Sciences 2021; 22(19): 10539 doi: 10.3390/ijms221910539
|
| 144 |
Quanzhong Su, Junying Song, Xiaoyi Zhang, Yuhuan Jiang, Hui Gao. Identification of AGT and CD44 in methotrexate-resistant colorectal cancer and reversal of methotrexate-resistance. Pathology - Research and Practice 2022; 229: 153717 doi: 10.1016/j.prp.2021.153717
|
| 145 |
Yangqian Shi, Chunliang Zhang, Wanyu Cao, Luyi Li, Kaili Liu, Hanyue Zhu, Fikadu Balcha, Yong Fang. Extracellular vesicles from Lacticaseibacillus paracasei PC-H1 inhibit HIF-1α-mediated glycolysis of colon cancer. Future Microbiology 2024; 19(3): 227 doi: 10.2217/fmb-2023-0144
|
| 146 |
Zhenyu Xu, Hui Jiang, Yanhong Zhu, Huifang Wang, Jia Jiang, Lu Chen, Wenke Xu, Tao Hu, Chi Hin Cho. Cryptotanshinone induces ROS-dependent autophagy in multidrug-resistant colon cancer cells. Chemico-Biological Interactions 2017; 273: 48 doi: 10.1016/j.cbi.2017.06.003
|
| 147 |
Wenli Liu, Yuqin Wang, Lijie Xia, Jinyao Li. Research Progress of Plant-Derived Natural Products against Drug-Resistant Cancer. Nutrients 2024; 16(6): 797 doi: 10.3390/nu16060797
|
| 148 |
Wei Zhang, Ying-Fang Fan, Chao-Yun Cai, Jing-Quan Wang, Qiu-Xu Teng, Zi-Ning Lei, Leli Zeng, Pranav Gupta, Zhe-Sheng Chen. Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01097
|
| 149 |
Haruko Takahashi, Iva Sovadinova, Kazuma Yasuhara, Satyavani Vemparala, Gregory A. Caputo, Kenichi Kuroda. Biomimetic antimicrobial polymers—Design, characterization, antimicrobial, and novel applications. WIREs Nanomedicine and Nanobiotechnology 2023; 15(3) doi: 10.1002/wnan.1866
|
| 150 |
Aranka Brockmueller, Anjana Sajeev, Lenka Koklesova, Samson Mathews Samuel, Peter Kubatka, Dietrich Büsselberg, Ajaikumar B. Kunnumakkara, Mehdi Shakibaei. Resveratrol as sensitizer in colorectal cancer plasticity. Cancer and Metastasis Reviews 2024; 43(1): 55 doi: 10.1007/s10555-023-10126-x
|
| 151 |
Domenico Ribatti, Roberto Tamma, Tiziana Annese. Epithelial-Mesenchymal Transition in Cancer: A Historical Overview. Translational Oncology 2020; 13(6): 100773 doi: 10.1016/j.tranon.2020.100773
|
| 152 |
Yan‐Yan Chen, Shi‐Yuan Wen, Chun‐Miao Deng, Xing‐Feng Yin, Zheng‐Hua Sun, Miao‐Miao Jiang, Qing‐Yu He. Proteomic Analysis Reveals that Odoroside A Triggers G2/M Arrest and Apoptosis in Colorectal Carcinoma Through ROS‐p53 Pathway. PROTEOMICS 2019; 19(15) doi: 10.1002/pmic.201900092
|
| 153 |
Anna-Lena Scherr, Andreas Mock, Georg Gdynia, Nathalie Schmitt, Christoph E. Heilig, Felix Korell, Praveen Rhadakrishnan, Paula Hoffmeister, Klaus H. Metzeler, Klaus Schulze-Osthoff, Anna L. Illert, Melanie Boerries, Jörg Trojan, Oliver Waidmann, Johanna Falkenhorst, Jens Siveke, Philipp J. Jost, Michael Bitzer, Nisar P. Malek, Loredana Vecchione, Ivan Jelas, Benedikt Brors, Hanno Glimm, Albrecht Stenzinger, Svetlana P. Grekova, Tobias Gehrig, Henning Schulze-Bergkamen, Dirk Jäger, Peter Schirmacher, Mathias Heikenwalder, Benjamin Goeppert, Martin Schneider, Stefan Fröhling, Bruno C. Köhler. Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer. Cell Death & Disease 2020; 11(10) doi: 10.1038/s41419-020-03092-7
|
| 154 |
Mehdi Rahmanian, Amir Seyfoori, Mohsen Ghasemi, Milad Shamsi, Ahmad Rezaei Kolahchi, Hassan Pezeshgi Modarres, Amir Sanati-Nezhad, Keivan Majidzadeh-A. In-vitro tumor microenvironment models containing physical and biological barriers for modelling multidrug resistance mechanisms and multidrug delivery strategies. Journal of Controlled Release 2021; 334: 164 doi: 10.1016/j.jconrel.2021.04.024
|
| 155 |
Ana P. S. Koltun, José Trobia, Antonio M. Batista, Ervin K. Lenzi, Moises S. Santos, Fernando S. Borges, Kelly C. Iarosz, Iberê L. Caldas, Enrique C. Gabrick. Fractional Tumour-Immune Model with Drug Resistance. Brazilian Journal of Physics 2024; 54(2) doi: 10.1007/s13538-024-01417-x
|
| 156 |
María Belén Novoa Díaz, María Julia Martín, Claudia Gentili. Tumor microenvironment involvement in colorectal cancer progression <i>via</i> Wnt/β-catenin pathway: Providing understanding of the complex mechanisms of chemoresistance. World Journal of Gastroenterology 2022; 28(26): 3027-3046 doi: 10.3748/wjg.v28.i26.3027
|
| 157 |
Sanaz Salek, Elham Moazamian, Afshin Mohammadi Bardbori, Seyedeh Azra Shamsdin. The anticancer effect of potential probiotic L. fermentum and L. plantarum in combination with 5-fluorouracil on colorectal cancer cells. World Journal of Microbiology and Biotechnology 2024; 40(5) doi: 10.1007/s11274-024-03929-9
|
| 158 |
Pedro Pedrosa, M. Luísa Corvo, Margarida Ferreira-Silva, Pedro Martins, Manuela Colla Carvalheiro, Pedro M. Costa, Carla Martins, L. M. D. R. S. Martins, Pedro V. Baptista, Alexandra R. Fernandes. Targeting Cancer Resistance via Multifunctional Gold Nanoparticles. International Journal of Molecular Sciences 2019; 20(21): 5510 doi: 10.3390/ijms20215510
|
| 159 |
Soghra Bagheri, Ali A. Saboury. Hypothesis of using albumin to improve drug efficacy in cancers accompanied by hypoalbuminemia. Xenobiotica 2021; 51(7): 778 doi: 10.1080/00498254.2021.1929557
|
| 160 |
Prasath Manogaran, Aparna Anandan, Viswanadha Vijaya Padma. Isoliensinine augments the therapeutic potential of paclitaxel in multidrug‐resistant colon cancer stem cells and induced mitochondria‐mediated cell death. Journal of Biochemical and Molecular Toxicology 2023; 37(8) doi: 10.1002/jbt.23395
|
| 161 |
Sadra Samavarchi Tehrani, Fataneh Esmaeili, Moein Shirzad, Golnaz Goodarzi, Tooba Yousefi, Mahmood Maniati, Mortaza Taheri‐Anganeh, Amir Anushiravani. The critical role of circular RNAs in drug resistance in gastrointestinal cancers. Medical Oncology 2023; 40(4) doi: 10.1007/s12032-023-01980-4
|
| 162 |
Xiaogang Shen, Xiaofei Zuo, Liang Liang, Lin Wang, Bin Luo. Integrating machine learning and single-cell trajectories to analyze T-cell exhaustion to predict prognosis and immunotherapy in colon cancer patients. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1162843
|
| 163 |
Tapas Pradhan, Vikas Kumar, Evangeline Surya H, R. Krishna, Samu John, V. T. Jissa, S. Anjana, K. Chandramohan, S. Asha Nair. STIL Endows Oncogenic and Stem-Like Attributes to Colorectal Cancer Plausibly by Shh and Wnt Signaling. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.581671
|
| 164 |
Lijun Song, Jiabo Chen, Yuxuan Feng, Yujing Zhou, Feng Li, Guiqin Dai, Yue Yuan, Haosen Yi, Yupei Qian, Siyan Yang, Yang Chen, Wenchang Zhao. The Preparation of Gen-NH2-MCM-41@SA Nanoparticles and Their Anti-Rotavirus Effects. Pharmaceutics 2022; 14(7): 1337 doi: 10.3390/pharmaceutics14071337
|
| 165 |
Kodappully S. Siveen, Afsheen Raza, Eiman I. Ahmed, Abdul Q. Khan, Kirti S. Prabhu, Shilpa Kuttikrishnan, Jericha M. Mateo, Hatem Zayed, Kakil Rasul, Fouad Azizi, Said Dermime, Martin Steinhoff, Shahab Uddin. The Role of Extracellular Vesicles as Modulators of the Tumor Microenvironment, Metastasis and Drug Resistance in Colorectal Cancer. Cancers 2019; 11(6): 746 doi: 10.3390/cancers11060746
|
| 166 |
Tatyana Grigoreva, Aleksandra Sagaidak, Angelina Romanova, Daria Novikova, Aleksander Garabadzhiu, Viacheslav Tribulovich. Establishment of drug-resistant cell lines under the treatment with chemicals acting through different mechanisms. Chemico-Biological Interactions 2021; 344: 109510 doi: 10.1016/j.cbi.2021.109510
|
| 167 |
Zhujun Xu. CRISPR/Cas9-mediated silencing of CD44: unveiling the role of hyaluronic acid-mediated interactions in cancer drug resistance. Naunyn-Schmiedeberg's Archives of Pharmacology 2023; doi: 10.1007/s00210-023-02840-8
|
| 168 |
Li-Min Mu, Rui-Jun Ju, Rui Liu, Ying-Zi Bu, Jing-Ying Zhang, Xue-Qi Li, Fan Zeng, Wan-Liang Lu. Dual-functional drug liposomes in treatment of resistant cancers. Advanced Drug Delivery Reviews 2017; 115: 46 doi: 10.1016/j.addr.2017.04.006
|
| 169 |
Dilpreet Kaur Dhiman, Sankar Nath Sanyal, Vivek Vaish. Imatinib exhibit synergistic pleiotropy in the prevention of colorectal cancer by suppressing proinflammatory, cell survival and angiogenic signaling. Cellular Signalling 2020; 76: 109803 doi: 10.1016/j.cellsig.2020.109803
|
| 170 |
Alice A. Ramos, Tânia Almeida, Bruna Lima, Eduardo Rocha. Cytotoxic activity of the seaweed compound fucosterol, alone and in combination with 5-fluorouracil, in colon cells using 2D and 3D culturing. Journal of Toxicology and Environmental Health, Part A 2019; 82(9): 537 doi: 10.1080/15287394.2019.1634378
|
| 171 |
Mingzhen Zhang, Chunhua Yang, Xiangji Yan, Junsik Sung, Pallavi Garg, Didier Merlin. Highly Biocompatible Functionalized Layer‐by‐Layer Ginger Lipid Nano Vectors Targeting P‐Selectin for Delivery of Doxorubicin to Treat Colon Cancer. Advanced Therapeutics 2019; 2(12) doi: 10.1002/adtp.201900129
|
| 172 |
Blanca Cáceres, Alberto Ramirez, Esmeralda Carrillo, Gema Jimenez, Carmen Griñán-Lisón, Elena López-Ruiz, Yaiza Jiménez-Martínez, Juan Marchal, Houria Boulaiz. Deciphering the Mechanism of Action Involved in Enhanced Suicide Gene Colon Cancer Cell Killer Effect Mediated by Gef and Apoptin. Cancers 2019; 11(2): 264 doi: 10.3390/cancers11020264
|
| 173 |
Yanfeng Liu, Lei Wu, Kai Li, Fengrui Liu, Li Wang, Dongling Zhang, Jing Zhou, Xuan Ma, Shengyu Wang, Shuanying Yang. Ornithine aminotransferase promoted the proliferation and metastasis of non‐small cell lung cancer via upregulation of miR‐21. Journal of Cellular Physiology 2019; 234(8): 12828 doi: 10.1002/jcp.27939
|
| 174 |
Crescenzo Massaro, Elham Safadeh, Giulia Sgueglia, Hendrik G. Stunnenberg, Lucia Altucci, Carmela Dell’Aversana. MicroRNA-Assisted Hormone Cell Signaling in Colorectal Cancer Resistance. Cells 2020; 10(1): 39 doi: 10.3390/cells10010039
|
| 175 |
Jie Yin, Xiping Shen, Mei Li, Fangying Ni, Li Xu, Hua Lu. miR-329 regulates the sensitivity of 5-FU in chemotherapy of colorectal cancer by targeting E2F1. Oncology Letters 2018; doi: 10.3892/ol.2018.9121
|
| 176 |
Farida Elbassiouni, Wafaa El-Kholy, El-Sayed Elhabibi, Sarah Albogami, Eman Fayad. Comparative Study between Curcumin and Nanocurcumin Loaded PLGA on Colon Carcinogenesis Induced Mice. Nanomaterials 2022; 12(3): 324 doi: 10.3390/nano12030324
|
| 177 |
Alejandro J. Español, Agustina Salem, María Di Bari, Ilaria Cristofaro, Yamila Sanchez, Ada M. Tata, María E. Sales, Irina V. Lebedeva. The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M2 receptor subtype. PLOS ONE 2020; 15(9): e0226450 doi: 10.1371/journal.pone.0226450
|
| 178 |
Bi-Qing Cai, Wan-Meng Chen, Jia Zhao, Wei Hou, Jian-Cai Tang, Dali Zheng. Nrf3 Promotes 5-FU Resistance in Colorectal Cancer Cells via the NF-κB/BCL-2 Signaling Pathway In Vitro and In Vivo. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/9355555
|
| 179 |
Alice C. O’Farrell, Monika A. Jarzabek, Andreas U. Lindner, Steven Carberry, Emer Conroy, Ian S. Miller, Kate Connor, Liam Shiels, Eugenia R. Zanella, Federico Lucantoni, Adam Lafferty, Kieron White, Mariangela Meyer Villamandos, Patrick Dicker, William M. Gallagher, Simon A. Keek, Sebastian Sanduleanu, Philippe Lambin, Henry C. Woodruff, Andrea Bertotti, Livio Trusolino, Annette T. Byrne, Jochen H. M. Prehn. Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft Models. Cancers 2020; 12(10): 2978 doi: 10.3390/cancers12102978
|
| 180 |
RamaRao Malla, Ganji Ganji.
Citrus Flavones Luteolin and Apigenin Target Fundamental Mechanisms in Colon Cancer
. Onco Therapeutics 2022; 9(2): 57 doi: 10.1615/OncoTherap.2022045072
|
| 181 |
Céline Hervieu, Niki Christou, Serge Battu, Muriel Mathonnet. The Role of Cancer Stem Cells in Colorectal Cancer: From the Basics to Novel Clinical Trials. Cancers 2021; 13(5): 1092 doi: 10.3390/cancers13051092
|
| 182 |
Ke YAN, Ying WANG, Bao-Fei YAN, Yu-Lu MA, Yue-Dong YANG, Shi-Lin DAI, Fang FANG, Si-Cheng WU, Xiu-Xiu WANG, Heng-Bin WANG, Dan YANG, Liu-Qing DI, Hai-Bo CHENG, Jia LIU, Sheng-Jin LIU. Establishment of X-ray diffraction fingerprints for identification of different configuration Realgar and its antitumor activity. Chinese Journal of Analytical Chemistry 2023; 51(5): 100212 doi: 10.1016/j.cjac.2022.100212
|
| 183 |
Mathias Dahlmann, Rebecca Werner, Benedikt Kortüm, Dennis Kobelt, Wolfgang Walther, Ulrike Stein. Restoring Treatment Response in Colorectal Cancer Cells by Targeting MACC1-Dependent ABCB1 Expression in Combination Therapy. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00599
|
| 184 |
Habiba Tariq, Zobia Noreen, Aftab Ahmad, Laraib Khan, Mashhood Ali, Muhammad Malik, Aneela Javed, Faisal Rasheed, Alina Fatima, Tanil Kocagoz, Ugur Sezerman, Habib Bokhari, Grzegorz Woźniakowski. Colibactin possessing E. coli isolates in association with colorectal cancer and their genetic diversity among Pakistani population. PLOS ONE 2022; 17(11): e0262662 doi: 10.1371/journal.pone.0262662
|
| 185 |
Cornelia Amalinei, Diana-Lavinia Pricope, Adriana Grigoras¸. Cancer Stem Cells and Signaling Pathways. 2024; : 185 doi: 10.1016/B978-0-443-13212-4.00018-0
|
| 186 |
Chung-Yen Huang, Ching-Ying Huang, Yu-Chen Pai, Been-Ren Lin, Tsung-Chun Lee, Pi-Hui Liang, Linda Chia-Hui Yu. Glucose Metabolites Exert Opposing Roles in Tumor Chemoresistance. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01282
|
| 187 |
Gabriel Cutshaw, Nora Hassan, Saji Uthaman, Xiaona Wen, Bhuminder Singh, Anwesha Sarkar, Rizia Bardhan. Monitoring Metabolic Changes in Response to Chemotherapies in Cancer with Raman Spectroscopy and Metabolomics. Analytical Chemistry 2023; 95(35): 13172 doi: 10.1021/acs.analchem.3c02073
|
| 188 |
Yong-Qiang Hou, Ying-Ying Wang, Xing-Can Wang, Yao Liu, Chun-Ze Zhang, Zhe-Sheng Chen, Zhe Zhang, Wei Wang, De-Xin Kong. Multifaceted anti-colorectal tumor effect of digoxin on HCT8 and SW620 cells in vitro
. Gastroenterology Report 2020; 8(6): 465 doi: 10.1093/gastro/goaa076
|
| 189 |
Entaz Bahar, Ji-Ye Kim, Hyonok Yoon. Chemotherapy Resistance Explained through Endoplasmic Reticulum Stress-Dependent Signaling. Cancers 2019; 11(3): 338 doi: 10.3390/cancers11030338
|
| 190 |
Ping Qiu, Jingqun Liu, Lisha Zhao, Pinghu Zhang, Weike Wang, Dan Shou, Jinjun Ji, Changyu Li, Kequn Chai, Yu Dong. Inoscavin A, a pyrone compound isolated from a Sanghuangporus vaninii extract, inhibits colon cancer cell growth and induces cell apoptosis via the hedgehog signaling pathway. Phytomedicine 2022; 96: 153852 doi: 10.1016/j.phymed.2021.153852
|
| 191 |
Amirsaeed Sabeti Aghabozorgi, Mostafa Moradi Sarabi, Reza Jafarzadeh-Esfehani, Shabnaz Koochakkhani, Marziyeh Hassanzadeh, Soudabeh Kavousipour, Ebrahim Eftekhar. Molecular determinants of response to 5-fluorouracil-based chemotherapy in colorectal cancer: The undisputable role of micro-ribonucleic acids. World Journal of Gastrointestinal Oncology 2020; 12(9): 942-956 doi: 10.4251/wjgo.v12.i9.942
|
| 192 |
Yi-Min Shao, Yong Wu. Inhibitory effects of piperine on proliferation, migration, and invasion of human colon cancer SW480 cells. World Chinese Journal of Digestology 2021; 29(12): 639 doi: 10.11569/wcjd.v29.i12.639
|
| 193 |
Elena Kazakova, Militsa Rakina, Tatiana Sudarskikh, Pavel Iamshchikov, Anna Tarasova, Liubov Tashireva, Sergei Afanasiev, Alexei Dobrodeev, Lilia Zhuikova, Nadezhda Cherdyntseva, Julia Kzhyshkowska, Irina Larionova. Angiogenesis regulators S100A4, SPARC and SPP1 correlate with macrophage infiltration and are prognostic biomarkers in colon and rectal cancers. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1058337
|
| 194 |
Vineela Parvathaneni, Rasha S. Elbatanony, Snehal K. Shukla, Nishant S. Kulkarni, Dipti D. Kanabar, Gautam Chauhan, Seyoum Ayehunie, Zhe-Sheng Chen, Aaron Muth, Vivek Gupta. Bypassing P-glycoprotein mediated efflux of afatinib by cyclodextrin complexation – Evaluation of intestinal absorption and anti-cancer activity. Journal of Molecular Liquids 2021; 327: 114866 doi: 10.1016/j.molliq.2020.114866
|
| 195 |
Liangpan Shi, Yibin Su, Zhihua Zheng, Jinyu Qi, Weidong Wang, Cunchuan Wang. miR‑146b‑5p promotes colorectal cancer progression by targeting TRAF6. Experimental and Therapeutic Medicine 2022; 23(3) doi: 10.3892/etm.2022.11155
|
| 196 |
Shujie Liu, Xiaonan Sima, Xingzhu Liu, Hongping Chen. Zinc Finger Proteins: Functions and Mechanisms in Colon Cancer. Cancers 2022; 14(21): 5242 doi: 10.3390/cancers14215242
|
| 197 |
Qianshi Zhang, Zhen Feng, Yongnian Zhang, Shasha Shi, Yu Zhang, Shuangyi Ren, Toshimi Chiba. Identification and Verification of a 17 Immune-Related Gene Pair Prognostic Signature for Colon Cancer. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/6057948
|
| 198 |
Xue-jia Kang, Hui-yuan Wang, Hui-ge Peng, Bin-fan Chen, Wen-yuan Zhang, Ai-hua Wu, Qin Xu, Yong-zhuo Huang. Codelivery of dihydroartemisinin and doxorubicin in mannosylated liposomes for drug-resistant colon cancer therapy. Acta Pharmacologica Sinica 2017; 38(6): 885 doi: 10.1038/aps.2017.10
|
| 199 |
Sara Jaramillo‐Carmona, Rafael Guillén‐Bejarano, Ana Jiménez‐Araujo, Rocío Rodríguez‐Arcos, Sergio López. In Vitro Toxicity of Asparagus Saponins in Distinct Multidrug‐Resistant Colon Cancer Cells. Chemistry & Biodiversity 2018; 15(11) doi: 10.1002/cbdv.201800282
|
| 200 |
Rongrong Fu, Rui Chang, Andong Peng, Changshun Feng, Weifan Zhu, Yi Chen, Xue Tian, Rui Wang, Hui Yan, Dianlong Jia, Jun Li. Efficient treatment of colon cancer with codelivery of TRAIL and imatinib by liposomes. Pharmaceutical Development and Technology 2024; 29(1): 52 doi: 10.1080/10837450.2024.2301763
|
| 201 |
Isaac Micallef, Byron Baron. The Mechanistic Roles of ncRNAs in Promoting and Supporting Chemoresistance of Colorectal Cancer. Non-Coding RNA 2021; 7(2): 24 doi: 10.3390/ncrna7020024
|
| 202 |
Chengyuan Zhang, Xuemei Zhou, Hanyi Zhang, Xuanliang Han, Baijun Li, Ran Yang, Xing Zhou. Recent Progress of Novel Nanotechnology Challenging the Multidrug Resistance of Cancer. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.776895
|
| 203 |
Veronique Mathieu, Breana Laguera, Marco Masi, Sara Adriana Dulanto, Tanner W. Bingham, Lucas W. Hernandez, David Sarlah, Antonio Evidente, Denis L. J. Lafontaine, Alexander Kornienko, Michelle A. Lane. Amaryllidaceae Alkaloids Decrease the Proliferation, Invasion, and Secretion of Clinically Relevant Cytokines by Cultured Human Colon Cancer Cells. Biomolecules 2022; 12(9): 1267 doi: 10.3390/biom12091267
|
| 204 |
Hiromi Kurokawa, Hirofumi Matsui. The Cytotoxicity of Doxorubicin Can Be Accelerated by a Combination of Hyperthermia and 5-Aminolevulinic Acid. Antioxidants 2021; 10(10): 1531 doi: 10.3390/antiox10101531
|
| 205 |
Santosh Kumar, Valid Gahramanov, Shivani Patel, Julia Yaglom, Lukasz Kaczmarczyk, Ivan A. Alexandrov, Gabi Gerlitz, Mali Salmon-Divon, Michael Y. Sherman. Evolution of Resistance to Irinotecan in Cancer Cells Involves Generation of Topoisomerase-Guided Mutations in Non-Coding Genome That Reduce the Chances of DNA Breaks. International Journal of Molecular Sciences 2023; 24(10): 8717 doi: 10.3390/ijms24108717
|
| 206 |
Munmun Panda, Stuti Biswal, Bijesh K. Biswal. Evodiamine potentiates cisplatin-induced cell death and overcomes cisplatin resistance in non-small-cell lung cancer by targeting SOX9-β‐catenin axis. Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-024-09477-7
|
| 207 |
Qing Zhang, Haixu Zhang, Jiage Ding, Hongyan Liu, Huizhong Li, Hailong Li, Mengmeng Lu, Yangna Miao, Liantao Li, Junnian Zheng. Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models. Journal of Immunology Research 2018; 2018: 1 doi: 10.1155/2018/4263520
|
| 208 |
Shunjin Li, Yue Ren, Xuhang Lu, Yuequan Shen, Xue Yang. Cryo-EM structure of human ABCB8 transporter in nucleotide binding state. Biochemical and Biophysical Research Communications 2021; 557: 187 doi: 10.1016/j.bbrc.2021.04.007
|
| 209 |
Henis Patel, Siddhant Palekar, Akanksha Patel, Ketan Patel. Ibrutinib amorphous solid dispersions with enhanced dissolution at colonic pH for the localized treatment of colorectal cancer. International Journal of Pharmaceutics 2023; 641: 123056 doi: 10.1016/j.ijpharm.2023.123056
|
| 210 |
Jingqi Shi, Dongbo Jiang, Shuya Yang, Yuanjie Sun, Jing Wang, Xiyang Zhang, Yang Liu, Yuchen Lu, Kun Yang. Molecular profile reveals immune-associated markers of lymphatic invasion in human colon adenocarcinoma. International Immunopharmacology 2020; 83: 106402 doi: 10.1016/j.intimp.2020.106402
|
| 211 |
PULI SAGAR, RAMASAMY RAVEENDRAN. CLEISTANTHIN B SHOWS A POTENT CYTOTOXIC ACTIVITY AGAINST COLORECTAL CANCER CELLS. Asian Journal of Pharmaceutical and Clinical Research 2022; : 94 doi: 10.22159/ajpcr.2022.v15i3.43953
|
| 212 |
Bouchra Ghazi, Adil El Ghanmi, Sarah Kandoussi, Amina Ghouzlani, Abdallah Badou. CAR T-cells for colorectal cancer immunotherapy: Ready to go?. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.978195
|
| 213 |
Mehri Joghataei, Fakhri Shahidi, Gholamreza Pouladfar, Seyed Ali Mortazavi, Abbas Ghaderi. Probiotic potential comparison of Lactobacillus strains isolated from Iranian traditional food products and human feces with standard probiotic strains. Journal of the Science of Food and Agriculture 2019; 99(15): 6680 doi: 10.1002/jsfa.9945
|
| 214 |
Srijeyagowri Murugaiyaa Pandiyan, Priyadharshini Shanmugaraj, Jeevitha Priya Manoharan, Subramanian Vidyalakshmi. A network pharmacological approach to reveal the multidrug resistance reversal and associated mechanisms of acetogenins against colorectal cancer. Journal of Biomolecular Structure and Dynamics 2022; 40(24): 13527 doi: 10.1080/07391102.2021.1990130
|
| 215 |
Elham Khalili, Ali Afgar, Azam Rajabpour, Seyed Hamid Aghaee-Bakhtiari, Khadijeh Jamialahmadi, Ladan Teimoori-Toolabi. MiR-548c-3p through suppressing Tyms and Abcg2 increases the sensitivity of colorectal cancer cells to 5-fluorouracil. Heliyon 2023; 9(11): e21775 doi: 10.1016/j.heliyon.2023.e21775
|
| 216 |
Jinxing Huang, Cheng Zhuang, Jie Chen, Xuanming Chen, Xiaojie Li, Ting Zhang, Bing Wang, Qiyi Feng, Xiuli Zheng, Meng Gong, Qiyong Gong, Kai Xiao, Kui Luo, Weimin Li. Targeted Drug/Gene/Photodynamic Therapy via a Stimuli‐Responsive Dendritic‐Polymer‐Based Nanococktail for Treatment of EGFR‐TKI‐Resistant Non‐Small‐Cell Lung Cancer. Advanced Materials 2022; 34(27) doi: 10.1002/adma.202201516
|
| 217 |
Xiaohan Shen, Jinming Han. Overexpression of gene DEP domain containing 1 and its clinical prognostic significance in colorectal cancer. Journal of Clinical Laboratory Analysis 2020; 34(12) doi: 10.1002/jcla.23634
|
| 218 |
Cihan Suleyman Erdogan, Yasmine Al Hassadi, Basak Aru, Bayram Yılmaz, Burcu Gemici. Combinatorial effects of melatonin and paclitaxel differ depending on the treatment scheme in colorectal cancer in vitro. Life Sciences 2022; 308: 120927 doi: 10.1016/j.lfs.2022.120927
|
| 219 |
Eric Chekwube Aniogo, Blassan Plackal Adimuriyil George, Heidi Abrahamse. The role of photodynamic therapy on multidrug resistant breast cancer. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0815-0
|
| 220 |
Yuedi Ding, Jun Fan, Zhenqiang Fan, Kai Zhang. γ-Tocotrienol reverses multidrug resistance of breast cancer cells through the regulation of the γ-Tocotrienol-NF-κB-P-gp axis. The Journal of Steroid Biochemistry and Molecular Biology 2021; 209: 105835 doi: 10.1016/j.jsbmb.2021.105835
|
| 221 |
Chih‐Yuan Huang, Ju‐Huei Chien, Kai‐Fu Chang, Chih‐Yen Hsiao, Ya‐Chih Huang, Yi‐Ting Chen, Ming‐Yi Hsu, Ming‐Chang Hsieh, Nu‐Man Tsai. Cedrus atlantica extract exerts antiproliferative effect on colorectal cancer through the induction of cell cycle arrest and apoptosis. Food Science & Nutrition 2022; 10(5): 1638 doi: 10.1002/fsn3.2786
|
| 222 |
Irina Nakashidze, Nina Petrović, Nino Kedelidze, Begum Dariya. Colon Cancer Diagnosis and Therapy Vol. 3. 2022; : 69 doi: 10.1007/978-3-030-72702-4_4
|
| 223 |
Chengqiong Mao, Yan Zhao, Fang Li, Zibo Li, Shaomin Tian, Waldemar Debinski, Xin Ming. P-glycoprotein targeted and near-infrared light-guided depletion of chemoresistant tumors. Journal of Controlled Release 2018; 286: 289 doi: 10.1016/j.jconrel.2018.08.005
|
| 224 |
Nanasaheb D. Thorat, Joanna Bauer, Syed A.M. Tofail, Victoria Gascón Pérez, Raghvendra A. Bohara, Hemraj M. Yadav. Silica nano supra-assembly for the targeted delivery of therapeutic cargo to overcome chemoresistance in cancer. Colloids and Surfaces B: Biointerfaces 2020; 185: 110571 doi: 10.1016/j.colsurfb.2019.110571
|
| 225 |
Min Xia, Xuyu Zu, Zuyao Chen, Gebo Wen, Jing Zhong. Noncoding RNAs in triple negative breast cancer: Mechanisms for chemoresistance. Cancer Letters 2021; 523: 100 doi: 10.1016/j.canlet.2021.09.038
|
| 226 |
Amirsaeed Sabeti Aghabozorgi, Samaneh Sharif, Reza Jafarzadeh-Esfehani, Saba Vakili, Mohammad Reza Abbaszadegan. Role of miRNA gene variants in the susceptibility and pharmacogenetics of colorectal cancer. Pharmacogenomics 2021; 22(5): 303 doi: 10.2217/pgs-2020-0159
|
| 227 |
Qiang Gao, Xiu-xiu Li, Yi-ming Xu, Jin-zhao Zhang, Shi-di Rong, Yan-qing Qin, Jing Fang. IRE1α-targeting downregulates ABC transporters and overcomes drug resistance of colon cancer cells. Cancer Letters 2020; 476: 67 doi: 10.1016/j.canlet.2020.02.007
|
| 228 |
Lixue Wang, Jinlong Chen, Qijun Chen, Hui Song, Ziqian Wang, Wen Xing, Siyao Jin, Xueying Song, Hua Yang, Wenhua Zhao, Kai Wang. The Gut Microbiota Metabolite Urolithin B Prevents Colorectal Carcinogenesis by Remodeling Microbiota and PD-L1/HLA-B. Oxidative Medicine and Cellular Longevity 2023; 2023: 1 doi: 10.1155/2023/6480848
|
| 229 |
Wen‐Shih Huang, Chien‐Tsong Lin, Cheng‐Nan Chen, Shun‐Fu Chang, Hsin‐I Chang, Ko‐Chao Lee. Metformin increases the cytotoxicity of oxaliplatin in human DLD‐1 colorectal cancer cells through down‐regulating HMGB1 expression. Journal of Cellular Biochemistry 2018; 119(8): 6943 doi: 10.1002/jcb.26898
|
| 230 |
Agnese Po, Anna Citarella, Giuseppina Catanzaro, Zein Mersini Besharat, Sofia Trocchianesi, Francesca Gianno, Claudia Sabato, Marta Moretti, Enrico De Smaele, Alessandra Vacca, Micol Eleonora Fiori, Elisabetta Ferretti. Hedgehog-GLI signalling promotes chemoresistance through the regulation of ABC transporters in colorectal cancer cells. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-70871-9
|
| 231 |
Himangshu Sonowal, Pabitra B. Pal, Jian-Jun Wen, Sanjay Awasthi, Kota V. Ramana, Satish K. Srivastava. Aldose reductase inhibitor increases doxorubicin-sensitivity of colon cancer cells and decreases cardiotoxicity. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-03284-w
|
| 232 |
Keefe Guang Zhi Lee, Maria V. Babak, Andrea Weiss, Paul J. Dyson, Patrycja Nowak‐Sliwinska, Diego Montagner, Wee Han Ang. Development of an Efficient Dual‐Action GST‐Inhibiting Anticancer Platinum(IV) Prodrug. ChemMedChem 2018; 13(12): 1210 doi: 10.1002/cmdc.201800105
|
| 233 |
Ting Liu, Jing Zhang, Kangdi Li, Lingnan Deng, Hongxiang Wang. Combination of an Autophagy Inducer and an Autophagy Inhibitor: A Smarter Strategy Emerging in Cancer Therapy. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00408
|
| 234 |
Xiao‑Li Zheng, Hong‑Gang Yu. Wnt6 contributes tumorigenesis and development of colon cancer via its effects on cell proliferation, apoptosis, cell‑cycle and migration. Oncology Letters 2018; doi: 10.3892/ol.2018.8729
|
| 235 |
Francis Yew Fu Tieng, Rashidah Baharudin, Nadiah Abu, Ryia-Illani Mohd Yunos, Learn-Han Lee, Nurul-Syakima Ab Mutalib. Single Cell Transcriptome in Colorectal Cancer—Current Updates on Its Application in Metastasis, Chemoresistance and the Roles of Circulating Tumor Cells. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00135
|
| 236 |
Zhendong Liu, Yuyang Xu, Xin Liu, Baochun Wang. PCDH7 knockdown potentiates colon cancer cells to chemotherapy via inducing ferroptosis and changes in autophagy through restraining MEK1/2/ERK/c-Fos axis. Biochemistry and Cell Biology 2022; 100(6): 445 doi: 10.1139/bcb-2021-0513
|
| 237 |
Na An, Ying Sun, Ligang Ma, Shengli Shi, Xiaoke Zheng, Weisheng Feng, Zhiming Shan, Yongguang Han, Le Zhao, Huiming Wu. Helveticoside Exhibited p53-dependent Anticancer Activity Against Colorectal Cancer. Archives of Medical Research 2020; 51(3): 224 doi: 10.1016/j.arcmed.2020.02.007
|
| 238 |
Hande Beklen, Gizem Gulfidan, Kazim Yalcin Arga, Adil Mardinoglu, Beste Turanli. Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal Cancer. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01273
|
| 239 |
Mostafa Mostafazadeh, Houman Kahroba, Sanya Haiaty, Abbas P. TazeKand, Nasser Samadi, Reza Rahbarghazi, Mohammad Nouri. In vitro exosomal transfer of Nrf2 led to the oxaliplatin resistance in human colorectal cancer LS174T cells. Cell Biochemistry and Function 2022; 40(4): 391 doi: 10.1002/cbf.3703
|
| 240 |
Nina Rembiałkowska, Vitalij Novickij, Dagmara Baczyńska, Magda Dubińska-Magiera, Jolanta Saczko, Julia Rudno-Rudzińska, Magdalena Maciejewska, Julita Kulbacka. Micro- and Nanosecond Pulses Used in Doxorubicin Electrochemotherapy in Human Breast and Colon Cancer Cells with Drug Resistance. Molecules 2022; 27(7): 2052 doi: 10.3390/molecules27072052
|
| 241 |
Harmeet Kaur, Jasbir Singh, Balasubramanian Narasimhan. Synthesis and evaluation of novel naphthol diazenyl scaffold based Schiff bases as potential antimicrobial and cytotoxic agents against human colorectal carcinoma cell line (HT-29). BMC Chemistry 2019; 13(1) doi: 10.1186/s13065-019-0558-y
|
| 242 |
Veronika Skarkova, Adam Skarka, Monika Manethova, Afroditi A Stefanidi, Emil Rudolf. Silencing of E-cadherin expression leads to increased chemosensitivity to irinotecan and oxaliplatin in colorectal cancer cell lines. Human & Experimental Toxicology 2021; 40(12): 2063 doi: 10.1177/09603271211021479
|